MedPath

辉瑞投资有限公司

Ownership
-
Established
1998-06-01
Employees
-
Market Cap
-
Website
pfizer.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Sugemalimab Injection

Product Name
择捷美
Approval Number
国药准字S20210053
Approval Date
Dec 20, 2021
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.